US Merger & Acquisition SEC Filings — August 10, 2026

10-08-2026

Dune Acquisition Corp II filed an 8-K on August 10, 2026, reporting amendments to its articles of incorporation (Item 5.03), shareholder votes on unspecified matters (Item 5.07), and other events (Item 8.01). The filing does not disclose any specific merger or acquisition details, deal size, parties involved, or financial metrics. The filing is purely procedural with no quantitative data on transaction value, share counts, or financial performance, making it impossible to assess strategic rationale, valuation, or shareholder impact.

• · The filing is an 8-K with no disclosed merger or acquisition details.
• · No financial metrics, transaction value, or share counts are provided.
• · The filing references amendments to articles of incorporation and shareholder votes, typical of SPAC business combination processes.
• · No specific dates, parties, or deal terms are mentioned beyond the filing date of August 10, 2026.

10-08-2026

Amneal Pharmaceuticals has completed its acquisition of Kashiv BioSciences, creating a fully integrated global biosimilars leader with end-to-end R&D, manufacturing, and commercialization capabilities. The strategic deal positions Amneal to capitalize on a projected $300 billion global biologics loss-of-exclusivity opportunity over the next decade, establishing biosimilars as a major long-term growth pillar. The combined portfolio is expected to support a consistent cadence of multiple biosimilar launches each year, extending Amneal's growth profile through the 2030s.

• · Amneal has a portfolio of approximately 300 complex generic, specialty and biosimilar medicines
• · The company delivers more than 160 million prescriptions annually, primarily in the United States
• · Amneal's segments include Affordable Medicines (retail generics, injectables, biosimilars), Specialty (neurology, endocrinology), and AvKARE (distribution to federal, retail, and institutional customers)
• · Integration planning is underway focusing on combining development and manufacturing capabilities and advancing the biosimilar pipeline

10-08-2026

Byrna Technologies Inc. completed the acquisition of substantially all assets of Hero Defense Systems, LLC for aggregate consideration including $625,000 in cash (with $125,000 held in escrow for up to 18 months), 104,000 shares of Byrna common stock, assumption of certain liabilities, and a 3.5% royalty on net sales of Hero products (subject to a $250,000 minimum and $5,000,000 cap, terminating at the earlier of the fifth anniversary or reaching the cap). The acquisition expands Byrna's less-lethal product portfolio. No financial statements or pro forma information were provided, and no material relationship exists between the parties beyond the transaction agreements.

• · The acquisition closed on August 6, 2026.
• · The Stock Consideration of 104,000 shares was issued as restricted securities under Section 4(a)(2) of the Securities Act, with a six-month lock-up.
• · No underwriters were involved and no underwriting discounts or commissions were paid.
• · The Purchase Agreement was previously filed as Exhibit 2.1 to Byrna's 8-K on July 8, 2026.
• · No financial statements or pro forma financial information were provided with this filing.

10-08-2026

Onto Innovation Inc. completed its acquisition of a 27% minority equity stake in Rigaku Holdings Corporation for ¥113,078,356,600 billion (approximately US$720 million), deepening a strategic collaboration first announced in April 2026 to advance X-ray-based process control solutions for semiconductor manufacturing. The investment will be accounted for under the fair value option method, and Onto will nominate a director to Rigaku's board. The company cautions that forward-looking statements involve risks, including the ability to realize anticipated benefits from the partnership.

• · The investment was first announced in April 2026.
• · Onto Innovation will account for the investment under the fair value option method and will not consolidate Rigaku's financial results.
• · Onto Innovation will nominate a director to serve on Rigaku's board.
• · Forward-looking statements involve risks including ability to realize anticipated benefits of the investment and strategic partnership.

10-08-2026

The filing is an 8-K under Item 5.02 regarding the departure of directors or certain officers and compensatory arrangements. It does not disclose any merger or acquisition transaction, deal structure, strategic rationale, valuation, or regulatory approval pathway. No financial metrics, transaction values, or shareholder impact details are provided. The filing is purely informational about officer changes, with no quantitative data on deal size, premiums, or synergies.

10-08-2026

Quetta Acquisition Corp filed an Item 8.01 Other Events 8-K on August 10, 2026, indicating a material, non-specified corporate event. The filing size (252 KB) and event classification suggest a significant transaction, but no specific details about the merger, acquisition, or deal structure have been disclosed. Without explicit deal terms, valuation, or parties involved, the available information is limited to the filing event itself.

10-08-2026

Pinnacle Acquisition Corporation, a blank-check company, priced its $200 million initial public offering of 20,000,000 units at $10.00 per unit, with units trading on the NYSE under the symbol "PNAQ.U" starting August 7, 2026. The offering is expected to close on August 10, 2026, and the company intends to use the proceeds to pursue a merger or business combination, focusing on growth businesses. However, the company has not yet identified a target, and there is no guarantee the offering will close or that a business combination will be completed.

• · The company is a blank-check company incorporated in the Cayman Islands.
• · The company intends to focus on businesses with growth platforms, strong management teams, and opportunities for accretive acquisitions or capital structure optimization.
• · The underwriters have a 45-day option to purchase up to an additional 3,000,000 units to cover over-allotments.
• · The registration statement became effective on August 6, 2026.
• · The company has not yet identified any specific business combination target.

10-08-2026

East West Ave Acquisition Corporation completed its IPO of 10,000,000 units at $10.00 per unit, generating gross proceeds of $100,000,000. Concurrently, it sold 272,500 private units to sponsors at $10.00 per unit, raising an additional $2,725,000. A total of $100,500,000 from the offerings was placed in a trust account for public shareholders and underwriters.

• · IPO closed on August 3, 2026
• · 10,000,000 units sold at $10.00 per unit in IPO
• · 272,500 private units sold at $10.00 per unit to sponsors
• · Total trust account balance: $100,500,000
• · Trustee: Equiniti Trust Company, LLC

10-08-2026

Yorkville Acquisition Corp. (SPAC), Crypto.com, and Trump Media & Technology Group Corp. (TMTG) have mutually terminated their Business Combination Agreement (BCA) dated August 25, 2025, effective August 7, 2026. All parties have released each other from any claims related to the BCA and the contemplated transactions, and no termination fee is payable. The termination marks the end of the proposed three-way merger involving the SPAC, the crypto exchange, and the media company.

• · The BCA was originally dated August 25, 2025, and amended on October 31, 2025.
• · The termination is effective immediately as of August 7, 2026.
• · Sections 7.15, 10.1, and Article XI of the BCA survive the termination.
• · All ancillary documents (Contribution Agreements, License Agreements, Backstop Agreement, Sponsor Support Agreement, Voting Agreement) are automatically terminated.
• · The parties have agreed to a non-disparagement clause.
• · No termination fee is payable by any party.

10-08-2026

Ondas Holdings Inc. completed its acquisition of Cyberhawk, a global leader in AI-powered drone inspection and asset intelligence for critical infrastructure. The deal expands Ondas' capabilities in high-value industrial inspection markets, which are growing rapidly due to technology and regulatory advancements. However, the company issued inducement equity awards (RSUs and stock options) to 47 new employees, which will result in shareholder dilution.

• · The acquisition closed on August 10, 2026.
• · Inducement RSUs vest over various schedules: 1,097,687 shares vest semi-annually over two years; 460,000 shares vest one-third on August 10, 2027 then quarterly; 43,906 shares vest on closing date.
• · Stock options vest one-third on August 10, 2027 then in 24 equal monthly installments.
• · Ondas is a dual-purpose company serving defense, security, and critical infrastructure markets.